12900 Results (Page 264 of 516)
All Market Research Reports
Thailand Neurology Devices Market Analysis
Thailand's Neurology Devices Market size was valued at $xx Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of xx% from 2022-30 and will reach $xx Bn in 2030. The increasing prevalence of neurological disorders in Thailand has a significant impact on the demand for neurology devices. The market is segmented by product type and by the end user. Some key players in this market include Medtronic, Johnson and Johnson, Siemens, GE Healthcare, Philips Healthcare, and Boston Scientific.
Thailand HIV Drugs Market Analysis
This report presents a strategic analysis of the Thailand HIV Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Thailand HIV Drugs Market, offering unmatched value, accuracy, and expert insights.
Philippines Addiction Therapeutics Market Analysis
Philippines addiction therapeutics market was valued at $22 Mn in 2022 and is estimated to reach $39 Mn in 2030, exhibiting a CAGR of 7.4% during the forecast period. The market for addiction therapies has expanded significantly as a result of increased awareness of mental health issues, particularly drug addiction and misuse. The top pharmaceutical firms in the market for addiction therapeutics include United Laboratories, Pfizer, GlaxoSmithKline, AstraZeneca, Merck, Boehringer Ingelheim, Sanofi, Bayer, Abbott, Pharmaceutical and Healthcare Association of Philippines (PHAP).
Thailand ENT Devices Market Analysis
Thailand's ENT Devices Market is projected to grow from $28 Mn in 2022 to $45 Mn by 2030, registering a CAGR of 6.1% during the forecast period of 2022-30. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the Thailand ENT devices market include KMS Medical, 4C Medical Instrument, and Nitan Medical.
Mexico Addiction Therapeutics Market Analysis
Mexico addiction therapeutics market was valued at $152 Mn in 2022 and is estimated to reach $263 Mn in 2030, exhibiting a CAGR of 7.15% during the forecast period. The development of the addiction treatment sector has been fuelled by increased public awareness brought about by anti-drug campaigns and encouraging government initiatives. Major players in the market, including Pfizer, Johnson & Johnson, Novartis, Bristol Myers Squibb, Merck, GlaxoSmithKline, Sanofi, AbbVie, Eli Lilly and Company, and Boehringer Ingelheim, are driving innovations in this field
Thailand Diabetes Therapeutics Market Analysis
Thailand's diabetes therapeutics market is expected to grow from $173 Mn in 2022 to $371 Mn in 2030 with a CAGR of 10.04% for the forecasted year 2022-30. Government policies promoting the awareness of diabetes and increased healthcare spending in Thailand have resulted in the expansion of the market. The Thailand diabetes therapeutics market is segmented by type, application, drug, route of administration, and distribution channel. Zuellig Pharma, Malachi, and Novartis are the major players in the Thailand diabetes therapeutics market.
Thailand Dermatology Drugs Market Analysis
By 2030, it is anticipated that the Thailand Dermatology drugs market will reach a value of $xx Mn from $xx Mn in 2022, growing at a CAGR of xx% during 2022-30. The market is primarily dominated by local players such as Siam Pharmaceuticals, Thai Nakorn Patana, and Bangkok Dusit Medical Services. The market is driven by the prevalence of dermatology conditions, awareness about dermatological health, and medical tourism. The dermatology drug market in Thailand is segmented by drug class, drug type, prescription mode, indication, route of administration, end-user, and distribution channel.
Thailand Dermatological Therapeutics Market Analysis
This report presents a strategic analysis of the Thailand Dermatological Therapeutics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Thailand Dermatological Therapeutics Market, offering unmatched value, accuracy, and expert insights.
Thailand Depression Therapeutics Market Analysis
This report presents a strategic analysis of the Thailand Depression Therapeutics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Thailand Depression Therapeutics Market, offering unmatched value, accuracy and expert insights.
Thailand Coronary Stents Market Analysis
Thailand Coronary Stents Market is expected to witness growth from $14 Mn in 2022 to $20 Mn in 2030 with a CAGR of 5.09% for the forecasted year 2022-30. One of the main factors propelling market expansion in Thailand is the increasing incidence and prevalence of coronary artery disease. Demand for coronary stents and related goods is projected to rise as more patients are given a diagnosis of coronary artery disease. The market is segmented by type, by mode of delivery, by materials and by end user. Some key players in this market include Xovic, Meticuly, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific and Philips Healthcare.
Malaysia Addiction Therapeutics Market Analysis
Malaysia addiction therapeutics market was valued at $16 Mn in 2022 and is estimated to reach $28 Mn in 2030, exhibiting a CAGR of 7.1% during the forecast period. The growing knowledge and understanding of mental health disorders, including substance abuse and addiction, has led to a major growth in the market for addiction therapeutics. The leading pharmaceutical companies in the addiction therapeutics market include Pfizer, GlaxoSmithKline, Novartis, Sanofi, AstraZeneca, Merck, Bayer, Abbott, Johnson & Johnson, and Boehringer Ingelheim.
Kenya Addiction Therapeutics Market Analysis
Kenya addiction therapeutics market was valued at $7 Mn in 2022 and is estimated to reach $13 Mn in 2030, exhibiting a CAGR of 8% during the forecast period. The anti-drug campaigns and supportive government initiatives have increased public awareness, which has led to a notable expansion of the addiction therapeutic industry. AbbVie, Indivior, Reckitt Benckiser Pharmaceuticals, Mylan Pharmaceuticals, Teva Pharmaceuticals, Sun Pharmaceutical Industries, Glenmark Pharmaceuticals, Alkermes, Lupin Pharmaceuticals, and Cipla are some of the leading companies operating in the market
Japan Addiction Therapeutics Market Analysis
Japan addiction therapeutics market was valued at $628 Mn in 2022 and is estimated to reach $1111 Mn in 2030, exhibiting a CAGR of 7.4% during the forecast period. The increasing awareness and recognition of mental health issues, such as substance abuse and addiction, has led to a sharp increase in the market for addiction therapies. A few prominent entities in the addiction therapeutics industry comprise Takeda Pharmaceutical Company, Astellas Pharma Inc., Daiichi Sankyo Company, Eisai Co., Otsuka Pharmaceutical Co., Mitsubishi Tanabe Pharma Corporation, Shionogi & Co., Chugai Pharmaceutical Co., Kyowa Kirin Co., and Sumitomo Dainippon Pharma
Thailand Contraceptive Devices Market Analysis
Thailand's Contraceptive Devices Market is expected to witness growth from $15 Mn in 2022 to $29 Mn in 2030 with a CAGR of 8.34% for the forecasted year 2022-30. In Thailand, due to a growing awareness of the benefits of family planning, there is a rising demand for contraceptive methods in the Market. The market is segmented by type and by gender. Some key players in this market include Unison Laboratories, Thai Nippon Rubber Industry, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer, and Teva Pharmaceutical.
Indonesia Addiction Therapeutics Market Analysis
Indonesia addiction therapeutics market was valued at $61 Mn in 2022 and is estimated to reach $103 Mn in 2030, exhibiting a CAGR of 6.9% during the forecast period. The market for addiction therapies has grown rapidly due to the growing knowledge and identification of mental health concerns, including substance abuse and addiction. Some of the leading players operating in the market include Kalbe Farma, PT Sanbe Farma, PT Tempo Scan Pacific Tbk, PT Dexa Medica, Combiphar, PT Phapros Tbk, Abbott, Pfizer, Novartis AG and GSK.
Germany Addiction Therapeutics Market Analysis
Germany addiction therapeutics market was valued at $370 Mn in 2022 and is estimated to reach $550 Mn in 2030, exhibiting a CAGR of 5.1% during the forecast period. The market for addiction treatment is growing as a result of the growing understanding and recognition of substance use disorders as serious public health issues. Indivior, Mundipharma, Reckitt Benckiser Pharmaceuticals, Lundbeck, Sun Pharmaceutical Industries, Sanofi, Pfizer, GlaxoSmithKline (GSK), Novartis, and AstraZeneca are some of the major market players
Thailand Cancer Immunotherapy Market Analysis
Thailand's cancer immunotherapy market is expected to witness growth from $135 Mn in 2022 to $240 Mn in 2030 with a CAGR of 7.4% for the forecasted year 2022-30. The increasing incidence of cancer and the improvements in healthcare spending in Thailand are responsible for the growth of the market. The Thailand cancer immunotherapy market is segmented by type, application, and end user. Silom Medical, Emergpharma, and Bayer are the major players in the Thailand cancer immunotherapy market.
Thailand Blockchain Technology in Healthcare Market Analysis
This report presents a strategic analysis of Thailand's Blockchain Technology in the Healthcare Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Thailand Blockchain Technology in the Healthcare Market, offering unmatched value, accuracy, and expert insights.
Thailand Antifungal Drugs Market Analysis
This report presents a strategic analysis of the Thailand Antifungal Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Thailand Antifungal Drugs Market, offering unmatched value, accuracy, and expert insights.
France Addiction Therapeutics Market Analysis
France addiction therapeutics market was valued at $278 Mn in 2022 and is estimated to reach $438 Mn in 2030, exhibiting a CAGR of 5.9% during the forecast period. The market for addiction treatments is being driven primarily by the growing recognition and understanding of substance use disorders as a serious public health issue. Major players in the market includes Indivior, Reckitt Benckiser Pharmaceuticals, Sanofi, Ethypharm, Mundipharma, Bioprojet Pharma, GlaxoSmithKline, Pfizer, Novartis and Merck KGaA
Egypt Addiction Therapeutics Market Analysis
Egypt addiction therapeutics market was valued at $28 Mn in 2022 and is estimated to reach $54 Mn in 2030, exhibiting a CAGR of 8.4% during the forecast period. The industry for addiction treatment is expanding as a result of public awareness raised by anti-drug campaigns and supportive government initiatives. Dominant key players operating in the market include Indivior, Alkermes, Reckitt Benckiser, Otsuka Pharmaceutical Co., Pfizer, Mallinckrodt, Purdue Pharma L.P., GlaxoSmithKline, Teva Pharmaceutical and Novartis
Canada Addiction Therapeutics Market Analysis
Canada addiction therapeutics market was valued at $808 Mn in 2022 and is estimated to reach $1378 Mn in 2030, exhibiting a CAGR of 6.9% during the forecast period. One of the key elements driving development in the addiction therapeutics market is increase in drug awareness campaigns and addiction & rehab centres among the population. Leading key players functioning in the market include Alkremes, Teva Pharmaceutical Industries, Glenmark Pharmaceuticals, Titan Pharmaceuticals, Pfizer, Inc., GSK, Johnson & Johnson, Perrigo, Cipla, Hikma Pharmaceuticals, Dr. Reddy’s Laboratories Limited, Indivior, and Mylan N.V
Brazil Addiction Therapeutics Market Analysis
Brazil addiction therapeutics market was valued at $253 Mn in 2022 and is estimated to reach $464 Mn in 2030, exhibiting a CAGR of 7.9% during the forecast period. The industry has grown as a result of several awareness efforts and government programs designed to discourage drug addiction and support medicine. Innovations in this field are being driven by major participants in the industry, including Pfizer, Sun Pharmaceutical Industries, Teva Pharmaceutical Industries, Titan Pharmaceutical, Novartis, Cipla, Mylan, Glenmark, and Alkermes.
Tanzania Radiotherapy Market Analysis
The Radiotherapy Therapeutics Market in Tanzania is dominated by a few domestic players such as Ocean Road Cancer Institute, Varian Medical Systems, and Siemens. The radiotherapy market in Tanzania is segmented into different types, technology, procedures, applications, and end-users. The significant risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives, and reimbursement policy. The demand for Tanzania Radiotherapy is increasing due to the rise in cancer cases in the country.
Tanzania Oncology Therapeutics Market Analysis
By 2030, it is anticipated that the Tanzania Oncology Therapeutics Market will reach a value of $148 Mn from $73 Mn in 2022, growing at a CAGR of 9.3% during 2022-30. The Oncology Therapeutics Market in Tanzania is dominated by a few domestic pharmaceutical companies such as MCL Pharmaceuticals, Labatec Pharma, and Pristine Pharma. The Oncology Therapeutics Market in Tanzania is segmented into different types of cancer and different therapy types. The major risk factors associated with cancer are diet, alcohol, tobacco, air pollution, and physical inactivity. The demand for Tanzania Oncology Therapeutics is increasing on account of the rise in initiatives taken by the Government of the country.